SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
-4.9%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.47B
AUM Growth
+$2.47B
(-8.5%)
Cap. Flow
-$25.5M
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
45.51%
Holding
112
New
16
Increased
28
Reduced
14
Closed
11
Top Buys
| 1 |
Home Depot
HD
|
$35.8M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$31.6M |
| 3 |
Bank of America
BAC
|
$31.5M |
| 4 |
89bio
ETNB
|
$30M |
| 5 |
Chipotle Mexican Grill
CMG
|
$27.1M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$97.4M |
| 2 |
Coca-Cola
KO
|
$51.7M |
| 3 |
Starbucks
SBUX
|
$47M |
| 4 |
CRH
CRH
|
$37.2M |
| 5 |
McDonald's
MCD
|
$30M |
Sector Composition
| 1 | Healthcare | 65.45% |
| 2 | Technology | 11.42% |
| 3 | Consumer Discretionary | 7.21% |
| 4 | Financials | 5.81% |
| 5 | Communication Services | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Merck
MRK
$210B
| $12.9M | 0.48% | 144,100 +91,100 | +172% | +$8.18M |
|
|
CTNM
52
Contineum Therapeutics
CTNM
$293M
| $12M | 0.45% | 1,720,000 | – | – |
|
53
ProKidney
PROK
$319M
| $10.8M | 0.4% | 12,341,266 | – | – |
|
|
MOLN
54
Molecular Partners
MOLN
$140M
| $8.62M | 0.32% | 2,221,494 | – | – |
|
55
Abbott
ABT
$231B
| $7.8M | 0.29% | 58,820 +25,300 | +75% | +$3.36M |
|
56
Monte Rosa Therapeutics
GLUE
$296M
| $7.26M | 0.27% | 1,563,798 | – | – |
|
57
Unity
U
$16.7B
| $6.65M | 0.25% | +339,560 | New | +$6.65M |
|
58
InflaRx
IFRX
$108M
| $6.61M | 0.25% | 6,483,910 +750,000 | +13% | +$765K |
|
|
WHWK
59
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $6.59M | 0.24% | +3,700,000 | New | +$6.59M |
|
60
Zura Bio
ZURA
$133M
| $6.27M | 0.23% | 4,860,939 | – | – |
|
|
BIOA
61
BioAge Labs, Inc. Common Stock
BIOA
$177M
| $5.46M | 0.2% | 1,452,336 | – | – |
|
62
Sutro Biopharma
STRO
$72.7M
| $4.86M | 0.18% | 7,462,495 | – | – |
|
63
Sanofi
SNY
$121B
| $4.64M | 0.17% | 83,701 -47,800 | -36% | -$2.65M |
|
64
Exact Sciences
EXAS
$8.98B
| $4.07M | 0.15% | 94,100 | – | – |
|
65
Disc Medicine
IRON
$2.07B
| $3.97M | 0.15% | +80,000 | New | +$3.97M |
|
66
Thermo Fisher Scientific
TMO
$186B
| $3.93M | 0.15% | 7,900 | – | – |
|
67
Kezar Life Sciences
KZR
$28.9M
| $3.5M | 0.13% | 716,759 | – | – |
|
68
Cencora
COR
$56.5B
| $3.47M | 0.13% | 12,488 | – | – |
|
69
Danaher
DHR
$147B
| $2.79M | 0.1% | 13,600 | – | – |
|
70
Elanco Animal Health
ELAN
$9.12B
| $2.66M | 0.1% | 253,600 | – | – |
|
71
Intuitive Surgical
ISRG
$170B
| $2.58M | 0.1% | 5,200 | – | – |
|
72
Alnylam Pharmaceuticals
ALNY
$58.5B
| $2.53M | 0.09% | +9,370 | New | +$2.53M |
|
|
AARD
73
Aardvark Therapeutics, Inc. Common Stock
AARD
$180M
| $2.35M | 0.09% | +312,500 | New | +$2.35M |
|
74
PepGen
PEPG
$38M
| $2.33M | 0.09% | 1,660,932 +486,611 | +41% | +$684K |
|
75
Mettler-Toledo International
MTD
$26.8B
| $2.32M | 0.09% | 1,964 | – | – |
|